谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A Phase 2 Trial Exploring the Significance of Homologous Recombination Status in Patients with Platinum Sensitive or Platinum Resistant Relapsed Ovarian Cancer Receiving Combination Cediranib and Olaparib

Joyce F. Liu,Niya Xiong,Robert M. Wenham,Andrea Wahner-Hendrickson,Deborah K. Armstrong,Nancy Chan,David M. O'Malley,Jung-Min Lee,Richard T. Penson,Mihaela C. Cristea,James L. Abbruzzese,Koji Matsuo,Alexander B. Olawaiye,William T. Barry,Su-Chun Cheng,Madeline Polak,Elizabeth M. Swisher,Geoffrey I. Shapiro,Elise C. Kohn,S. Percy Ivy,Ursula A. Matulonis

GYNECOLOGIC ONCOLOGY（2024）

引用 0|浏览34
关键词
Ovarian cancer,Anti-angiogenic,PARP inhibitor,Cediranib,Olaparib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要